Common questions about Xulane patch (FAQ)
Q: What is the difference between Xulane and the pill?
A: Xulane is a transdermal system (patch) applied to the skin once a week, while the pill is taken orally on a daily schedule. Official documents also indicate that the total systemic exposure to the estrogen component (Ethinyl Estradiol) may be higher with the patch than with a typical 35 microgram oral contraceptive pill.
Q: Can Xulane be used by people over 35?
A: Regulatory documents state that the patch is contraindicated (must not be used) in women over 35 who smoke due to an increased risk of serious heart and circulatory issues. For all women, official guidance suggests evaluating cardiovascular risk factors before beginning combination hormonal contraceptives, which includes the Xulane patch.
Q: Is there a maximum weight limit for people using Xulane?
A: The Xulane patch is contraindicated (must not be used) in women whose Body Mass Index (BMI) is ge 30 kg/m^2. Additionally, official information indicates the patch may be less effective in women who weigh 198 lbs (90 kg) or more.
Q: Can common over-the-counter pain relievers interact with Xulane?
A: Official drug interaction information notes that Acetaminophen, a common over-the-counter pain reliever, may potentially increase the plasma level of Ethinyl Estradiol, which is one of the hormones in Xulane. Official product labeling emphasizes the importance of a healthcare provider reviewing all medications and supplements.
Q: Do antibiotics reduce the effectiveness of the Xulane patch?
A: Official labeling specifically identifies Rifampin, a certain type of antibiotic, as an enzyme inducer that may decrease the contraceptive effectiveness of the patch. Some sources also note that certain other antibiotics, such as Amoxicillin, may reduce the effect of the estrogen component, potentially increasing the risk of pregnancy.
Q: What is the long-term research on the use of Xulane?
A: Clinical trials reviewed by regulatory bodies had a maximum follow-up duration of one year. Therefore, the official product labeling reflects that the full picture of effects that may develop over a period longer than one year is not fully established.
Q: What happens if the Xulane patch comes off in the shower?
A: Official patient labeling provides specific, timed instructions for addressing a patch that has partially detached or fallen off, based on how long the patch was off the skin. These instructions detail when a new cycle must be started and when a non-hormonal back-up method is necessary. This protocol is intended to minimize the potential for reduced effectiveness.
Q: Can swimming affect how the Xulane patch works?
A: Official patient information emphasizes that the patch must adhere securely to the skin to deliver its intended dose. It is noted that detachment after water exposure, such as swimming, requires following the specific protocol for a loose or fallen patch.
Q: Is Xulane the same as the Ortho Evra patch?
A: Xulane is a branded generic version that contains the same active ingredients as the original patch, Ortho Evra, which has since been discontinued. Other generic equivalents are also available in the market.
Q: Does Xulane make it harder to get pregnant after stopping its use?
A: Official information describes the patch as a reversible method of contraception. Following discontinuation, some women may experience amenorrhea (absence of period) or oligomenorrhea (infrequent periods), especially if they experienced this before starting hormonal birth control.
Q: How quickly does Xulane begin to work?
A: Official patient labeling defines specific initiation protocols that determine if a non-hormonal back-up method is necessary for the first seven days. The timing of when the patch is first applied relative to the menstrual cycle dictates when full effectiveness may be expected.
Q: What should a user do if they forget when to change the patch?
A: Official patient labeling provides distinct protocols for managing a delayed or missed patch change. The actions required, including whether to start a new cycle and use back-up contraception, depend strictly on which week of the four-week cycle the delay occurs.
Q: Can exercise affect the patch's adhesion?
A: Clinical trials reported that roughly 2% of patches completely detached and 3% partially detached during the studies. Official product information emphasizes that any detachment, regardless of the cause, requires following the specific instructions for a loose or fallen patch.
Q: Is it possible to be allergic to the materials in the Xulane patch?
A: Official prescribing information states that Xulane is contraindicated in users who are hypersensitive (allergic) to any of the product's components. The full Prescribing Information lists all active and inactive ingredients used to make the patch.
Q: Are there any dietary restrictions mentioned for people using Xulane?
A: While specific food restrictions are not listed in the main prescribing information, interaction data notes that the estrogen component (Ethinyl Estradiol) may increase the blood levels of caffeine. If there are concerns about diet or caffeine intake, official guidance requires discussion with a healthcare provider.
Q: What information is available about Xulane's effect on cholesterol levels?
A: Official labeling notes that combination hormonal contraceptives are generally known to affect lipid (fat and cholesterol) profiles, and the product information addresses the need for caution when used by women with pre-existing high triglyceride or cholesterol levels.
Q: Is it common for Xulane users to experience breast tenderness?
A: Yes, official adverse reaction data reports that breast symptoms, including discomfort, pain, or swelling, were frequently reported in clinical trials, occurring in ge 5% of users.
Q: Is there a generic version of the Xulane patch?
A: Xulane itself is a branded generic equivalent of the original patch (Ortho Evra). Additionally, other generic equivalents are available that contain the same active ingredients.
Q: Does Xulane offer any protection against sexually transmitted infections (STIs)?
A: No. Official safety information explicitly states that Xulane does not protect against HIV infection (AIDS) and other sexually transmitted infections (STIs).
Q: Is it necessary to use a backup method when starting Xulane?
A: Official patient labeling defines specific initiation protocols that determine if a non-hormonal back-up method is necessary for the first seven days. The requirement for a back-up method depends entirely on the timing of the first patch application relative to the start of the menstrual cycle.
Q: Are there different strengths of the Xulane patch?
A: Official product information states that Xulane is available in one strength. This strength is designed to deliver a fixed, established amount of the two hormonal components per day.
Q: Does exposure to sunlight or tanning affect the patch?
A: The patch must be stored in its original sealed foil pouch until use to protect it from light. There is no explicit regulatory statement regarding the effect of tanning or direct sun exposure on the patch's efficacy while it is being worn.
Q: Why is annual physical exam monitoring mentioned for Xulane users?
A: Regulatory documents mention that ongoing medical assessment is necessary due to the potential for risks, such as hypertension, to develop or increase over time during combination hormonal contraceptive therapy. Monitoring includes appropriate diagnostic tests both before and during use.
Q: Is it safe to get an MRI while wearing the Xulane patch?
A: Government safety alerts note that certain transdermal patches containing metal or foil may cause skin burns during an MRI. Therefore, official guidance requires checking with a healthcare provider or pharmacist to confirm if the patch contains metal and should be removed prior to the procedure.
